Joe Pitts

Based on recent HHS decisions to implement what they simply want rather than what is statutorily required, what assurances do we have that exchanges will be ready to enroll individuals in just 60 days?

For months, various administration officials, including HHS Secretary Sebelius, have been telling Congress that implementation of the President's healthcare law is on track.

More than 6,900 seniors in my district have gotten drug discounts worth $9.3 million.

The Affordable Care Act is providing 8,000 young adults with healthcare coverage through their parents' plan.

The chair thanks the gentleman and now recognizes the gentleman from Virginia, Mr. Griffith, for 5 minutes for questions.

Under the proposed Senate framework, FDA would be barred from requiring compounding manufacturers to submit NDAs and ANDAs pre-inspection and labeling requirements before these drugs reach patients.

Would it be better to regulate large-scale compounders under the manufacturing standards rather than establishing a new category?

Considering that they are more similar in function to manufacturers, should they be regulated within the manufacturing framework?

Let's put pen to paper and make sure the bad actors are not able to hide from clear enforcement authority.

Who at the Food and Drug Administration has been fired over this incident? Again, 53 Americans died, 700 are living with a disability.

But, honestly, all the laws in the world are not going to save a single patient if there is no one enforcing the law.

My goal has always been to draw a clear line on defining what a traditional compounding pharmacy is, and that should be regulated by the States, and what a manufacturer, a drug manufacturer is, which properly should be regulated by the FDA.

It is time not just to reform Medicaid. We actually need to reboot the entire system.

The expansion of the Medicaid program under the Affordable Care Act is not only something that makes tremendous sense for the health of vulnerable populations across the country, but for State economies as well.

Medicaid should be structured in a way that provides benefits to individuals in the most efficient and effective way.

We must first address these issues in the current program.

We have an obligation to ensure that the program provides quality health care to beneficiaries and has the flexibility to innovate to better serve this population.

Without objection that will be entered into the record, and I would also like to ask unanimous consent that the following documents be submitted for the record: a letter from the California Health Institute, a letter from the American…

I have sponsored H.R. 1416, which is the Cancer Patient Protection Act. This benefit to our seniors, our Medicare recipients, is essential.

H.R. 800 by Congressmen Whitfield and Green, which seeks to exclude prompt pay discounts from manufacturers to wholesalers from the calculation of ASP.

I would like to commend members on both sides of the aisle for their work on the part B drug benefit.

Today's hearing is an opportunity for us to examine Medicare's part B drug benefit and to assess how well it is working for both seniors and providers.

H.R. 1416, by Rep. Ellmers, which would terminate application of sequestration to certain physician-administered Part B drugs.

I'd like to commend Members on both sides of the aisle for their work on the Part B drug benefit.

H.R. 1428 by Dr. Burgess and Representative Kind which seeks to provide coverage for immunosuppressive drugs for kidney transplant recipients.